Catheterization and Cardiovascular Interventions · 2022 · 34 citations · 24 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyInterventional CardiologyBalloon AngioplastyCoronary AngioplastyCoronary Artery DiseaseCoronary AtherectomyPercutaneous Coronary InterventionStent PlacementAngiographic SuccessCalcified Coronary Lesion TreatmentCoronary Lesion AssessmentCoronary Lesion PreparationHistorical Control ComparisonsScoring Balloon AngioplastySeverely Calcified Coronary LesionsStent Expansion Assessment
Abstract Objectives To evaluate the safety and efficacy of lesion preparation using rotational atherectomy (RA) with consecutive cutting balloon angioplasty (Rota‐Cut). Background Whether the Rota‐Cut combination improves stent performance in severely calcified coronary lesions is unknown. Methods PREPARE‐CALC‐COMBO is a single‐arm prospective trial in which 110 patients were treated with a Rota‐Cut strategy before implantation of sirolimus‐eluting stents and compared with patients treated with modified balloon (MB, scoring or cutting) or RA from a historical cohort (the randomized PREPARE‐CALC trial). The study had two primary endpoints: in‐stent acute lumen gain (ALG) by quantitative angiographic analysis and stent expansion (SE) on optical coherence tomography. Results In‐stent ALG was significantly higher with Rota‐Cut compared to RA or MB alone (1.92 ± 0.45 mm vs. 1.74 ± 0.45 mm with MB vs. 1.70 ± 0.42 mm with RA; p = 0.001 and p < 0.001, respectively). SE was comparable between groups (75.1 ± 13.8% vs. 73.5 ± 13.3 with MB vs. 73.1 ± 12.2 with RA; p = 0.19 and p = 0.39, respectively). The Rota‐Cut combination resulted in higher minimal stent area (MSA) (7.1 ± 2.2mm 2 vs. 6.1 ± 1.7mm 2 with MB vs. 6.2 ± 1.9mm 2 with RA; p = 0.003 and p = 0.004, respectively). In‐hospital death occurred in one patient. Target vessel failure at 9 months was low and comparable between groups (8.2% vs. 8% with MB vs. 6% with RA; p = 1 and p = 0.79, respectively). Conclusion Rota‐Cut combination resulted in higher ALG and larger MSA compared with historical control of RA or MB alone, but was not associated with higher SE. Despite extensive lesion preparation, this strategy is safe, feasible, and associated with favorable clinical outcome at 9 months.
24
Clinical End Points in Coronary Stent Trials
Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations
Guillermo J. Tearney, Evelyn Regar, Takashi Akasaka et al. · Journal of the American College of Cardiology · 2012 · 1.8K citations · Full text
Patterns of Calcification in Coronary Artery Disease
Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pichard et al. · Circulation · 1995 · 670 citations
Medicine, Cardiology, Radiology +15